почта: bd@sidmexinovia.com
Телефон: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Главная >
Adhestop 25000IU Injection
Adhestop 25000IU Injection
Manufacturer/Marketed By : VARENYAM HEALTHCARE PVT LTD
$3.38 $3.04
Adhestop 25000IU Injection contains an active component such as Heparin. It is a widely used anticoagulant medication, meaning it prevents the formation of blood clots. It is commonly prescribed in...
Сворачиваемый текст идеально подходит для длинных текстов, таких как абзацы и описания. Это отличный способ предоставить людям больше информации, сохраняя при этом лаконичность макета. Вы можете связать текст с чем угодно, включая внешний веб-сайт или другую страницу. Вы можете настроить текстовое поле так, чтобы оно разворачивалось и сворачивалось при щелчке пользователя, позволяя ему прочитать больше или меньше информации.
HEPARIN
Active Pharmaceutical Ingredient
Adhestop 25000IU Injection
3,38 $
3,04 $
Adhestop 25000IU Injection contains an active component such as Heparin. It is a widely used anticoagulant medication, meaning it prevents the formation of blood clots. It is commonly prescribed in various medical situations to reduce the risk of clotting, especially in patients who are at higher risk for developing blood clots. Adhestop 25000IU Injection is commonly used in hospitals to prevent and treat deep vein thrombosis (DVT), pulmonary embolism (PE), and other conditions where the formation of blood clots is a concern. It is also used during certain surgical procedures and in dialysis to prevent clotting in the extracorporeal circuit. The effect varies among individuals, so its administration requires careful monitoring of blood clotting parameters, usually through the activated partial thromboplastin time (aPTT) test. The dosage may need to be adjusted to maintain therapeutic levels. In case of excessive bleeding or an overdose of Adhestop 25000IU Injection, its effects can be reversed using protamine sulfate, an antidote for this medication. Patients with known hypersensitivity or allergic reactions should not use Adhestop 25000IU Injection. While this medication is generally safe, it may not suit people with certain medical conditions, such as bleeding disorders or recent major surgeries. You must inform your healthcare provider about any existing medical conditions and medications you are taking before starting the therapy. Elderly individuals may be more susceptible to bleeding complications, and lower dosages or closer monitoring may be necessary. Impaired liver or kidney function can affect the metabolism and elimination of this medication, potentially leading to adverse effects. Dosing adjustments may be necessary for patients with these conditions.
Active Pharmaceutical Ingredient
Применение
• Deep vein thrombosis
• Pulmonary embolism
• Disseminated intravascular coagulation
• Venous thromboembolism prophylaxis
• Atrial fibrillation with a high risk of stroke
• Hemodialysis
• Pregnancy-related thrombosis
Преимущества
Adhestop 25000IU Injection enhances the activity of antithrombin III, a natural anticoagulant protein in the body. By binding to antithrombin III, this medication accelerates its inhibitory effect on clotting factors, particularly thrombin and factor Xa. This inhibition disrupts the blood coagulation cascade, preventing fibrin formation, an essential component of blood clots. As a result, this medication effectively reduces the risk of clot formation and growth, making it a valuable anticoagulant used in various medical conditions.
Побочные эффекты
Adhestop 25000IU Injection causes some side effects like all medications, although not everyone will experience them.
Наиболее распространенные побочные эффекты
• Bruising
• Hematomas
• Pain at Injection Site
• Redness at Injection Site
• Elevated Liver Enzymes
• Fever
• Nausea
• Vomiting
Распространенные побочные эффекты
• Severe allergic reactions, including rash, itching, swelling, severe dizziness, or difficulty breathing
• Bleeding
• Adhestop 25000IU Injection-induced thrombocytopenia (HIT)
• Osteoporosis (bone weakness)
Как использовать
Adhestop 25000IU Injection is typically administered by injection either intravenously (IV) or subcutaneously (under the skin). The specific dosage and administration method depends on the medical condition being treated, the patient's weight, age, and other factors, which a healthcare professional should determine. For IV use, this medication is usually given in a hospital setting under continuous monitoring to adjust the dosage as needed. Subcutaneous injections are often used for prophylactic purposes or in outpatient settings.
Рекомендации по безопасности
• Breast Feeding: While Adhestop 25000IU Injection is considered safe during breastfeeding, as with any medication, nursing mothers need to discuss their specific situation with a healthcare provider.
• Alcohol: Adhestop 25000IU Injection may affected by alcohol consumption. It's essential to consult with a healthcare professional about the suitability of alcohol consumption based on individual health conditions and the specific regimen.
• Liver: Adhestop 25000IU Injection is considered relatively safe for patients with liver impairment. Unlike other anticoagulant medications, this medication is not metabolized by the liver, and its elimination primarily occurs through the kidneys.
• Lungs: Adhestop 25000IU Injection is generally safe for the lungs, as it is an anticoagulant primarily used to prevent and treat blood clots in the circulatory system, not the lungs directly. It is often used to treat conditions like pulmonary embolism (PE), where blood clots block blood flow to the lungs.
• Driving: Adhestop 25000IU Injection does not directly affect a person's driving ability, as it is not known to cause drowsiness or impair cognitive and motor skills. Therefore, taking it, as prescribed will not likely interfere with one's ability to drive safely.
• Pregnancy: Adhestop 25000IU Injection is generally considered safe to use during pregnancy, and it is often preferred over certain other anticoagulants, especially vitamin K antagonists like warfarin. This preference is due to its minimal placental transfer, which means it does not cross the placenta to a significant extent and has a lower risk of harming the developing fetus.
Отказ от ответственности
Компания Sidmex Inovia стремится предоставлять точную и достоверную информацию; однако весь контент на этом веб-сайте, включая описания и состав продуктов, предназначен только для информационных целей и не должен рассматриваться как замена профессиональной медицинской консультации, диагностики или лечения.
Пользователям рекомендуется проконсультироваться с квалифицированным медицинским специалистом, прежде чем принимать какие-либо медицинские решения. Предоставленная информация не должна использоваться для самодиагностики или самолечения.
Все перечисленные продукты предназначены исключительно для B2B и оптовых запросов. Sidmex Inovia не пропагандирует прямое использование потребителями и стремится поддерживать, а не заменять отношения между медицинским работником и пациентом.
Названия продуктов, товарные знаки и бренды принадлежат их соответствующим владельцам, и их использование не подразумевает какой-либо связи или одобрения. Sidmex Inovia не несет ответственности за любые последствия, возникающие в результате использования информации, предоставленной на этом веб-сайте.











